Ustekinumab is effective and safe in the long‐term treatment of erythrodermic psoriasis: Multicenter study in daily practice
Abstract Background The treatment of erythrodermic psoriasis (EP) is challenging. Biological therapies have shown promising results in the long‐term management of this clinical variant, but most of the current available evidence is based on single case reports and short case series. Objectives To de...
Saved in:
Main Authors: | Clara Plana (Author), Maria J. Concha‐Garzón (Author), Vicen C. Rocamora (Author), Ofelia Baniandrés (Author), Rosa Feltes (Author), Jose L. López‐Estebaranz (Author), Joan Garcías‐Ladaria (Author), Jose‐Manuel Carrascosa (Author), Eva Vilarrasa (Author), Caridad Soria (Author), Belen Navajas (Author), Mar Llamas‐Velasco (Author), Esteban Dauden (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ustekinumab Treatment of Erythrodermic Psoriasis Occurring after Physical Stress: A Report of Two Cases
by: Rosita Saraceno, et al.
Published: (2013) -
Ustekinumab Efficacy and Safety in Children with Plaque, Erythrodermic and Palmoplanar Forms of Psoriasis: Retrospective Cohort Study
by: Nikolay N. Murashkin, et al.
Published: (2020) -
An itching plaque
by: Juan Garcias-Ladaria, et al.
Published: (2015) -
Whole exome sequencing approach to childhood onset familial erythrodermic psoriasis unravels a novel mutation of CARD14 requiring unusual high doses of ustekinumab
by: S. Signa, et al.
Published: (2019) -
Ustekinumab
by: Murat Borlu
Published: (2022)